Keebeck Wealth Management’s Gyre Therapeutics GYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,333	Closed	-$7.03K	–	261
2023 Q2	$7.03K	Hold	1,333	–	–	﹤0.01%	260
2023 Q1	$4.14K	Sell	1,333 -1,334	-50%	-$4.14K	﹤0.01%	249
2022 Q4	$10.6K	Buy	+2,667	New	+$10.6K	﹤0.01%	238